Table 1.
Baseline Characteristics
| Characteristic | Participants Enrolled |
Participants Completed 6 Weeks |
Participants Completed 12 Weeks |
|---|---|---|---|
| (N = 23) | (n = 14) | (n = 10) | |
| Age, y, mean | 59.9 | 59.6 | 60.3 |
| Male sex, % | 52.1 | 50.0 | 36.4 |
| Race, % | |||
| White | 73.9 | 71.4 | 81.8 |
| Black | 17.4 | 21.4 | 9.1 |
| COPD, % | 39.1 | 50.0 | 45.5 |
| Asthma, % | 8.7 | 14.3 | 18.2 |
| Diabetes, % | 17.4 | 7.1 | 9.1 |
| Smoking history | |||
| Current, % | 4.4 | 7.1 | 9.1 |
| Former, % | 91.3 | 92.9 | 90.9 |
| Pack-years | 34.3 | 36.8 | 36.4 |
| Type of NSCLC, % | |||
| Adenocarcinoma | 43.5 | 50.0 | 54.5 |
| Squamous cell carcinoma | 52.2 | 42.9 | 45.5 |
| Adenosquamous | 4.4 | 7.1 | 0 |
| Receiving chemotherapy, % | 87.0 | 85.7 | 82.8 |
| Lesion size, mm | 20.6 | 16.8 | 17.6 |
NSCLC = non-small cell lung cancer.